BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 316036)

  • 1. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy.
    Lanier LL; Babcock GF; Lynes MA; Haughton G
    J Natl Cancer Inst; 1979 Dec; 63(6):1417-22. PubMed ID: 316036
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM.
    Perek Y; Hurwitz E; Burowski D; Haimovich J
    J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes.
    Levy R; Meeker T; Lowder J; Levy S; Thielemans K; Warnke RA; Cleary ML; Sklar J
    Symp Fundam Cancer Res; 1986; 38():261-8. PubMed ID: 3529276
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen.
    Haughton G; Lanier LL; Babcock GF; Lynes MA
    J Immunol; 1978 Dec; 121(6):2358-62. PubMed ID: 82581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide.
    Campbell MJ; Esserman L; Levy R
    J Immunol; 1988 Nov; 141(9):3227-33. PubMed ID: 3049819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of 2 immunoglobulin isotypes, IgM and IgA, with identical idiotype in the B cell lymphoma I.29.
    Sitia R; Rubartelli A; Hammerling U
    J Immunol; 1981 Oct; 127(4):1388-94. PubMed ID: 6974189
    [No Abstract]   [Full Text] [Related]  

  • 8. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
    J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
    Kwak LW; Campbell M; Levy R
    Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum.
    Lanier LL; Babcock GF; Raybourne RB; Arnold LW; Warner NL; Haughton G
    J Immunol; 1980 Oct; 125(4):1730-6. PubMed ID: 6997386
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiidiotype antibody therapy of B-cell lymphoma.
    Brown SL; Miller RA; Levy R
    Semin Oncol; 1989 Jun; 16(3):199-210. PubMed ID: 2658083
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of innate and induced anti-idiotypic mechanisms in suppression of B cell tumors.
    Stevenson FK; George AJ; Tutt AL; Glennie MJ; Stevenson GT
    Monogr Allergy; 1987; 22():184-93. PubMed ID: 3501833
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
    Hatzubai A; Maloney DG; Levy R
    J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.
    Stevenson GT; Glennie MJ
    Cancer Surv; 1985; 4(1):213-44. PubMed ID: 3916080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lymphoid tumors with anti-idiotype antibodies.
    Stevenson GT; Stevenson FK
    Springer Semin Immunopathol; 1983; 6(1):99-115. PubMed ID: 6351310
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
    Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
    J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-idiotype antibodies reveal the existence of somatic mutation in human B cell lymphoma.
    Levy R; Levy S; Brown SL; Kon S; Carroll W
    Monogr Allergy; 1987; 22():194-203. PubMed ID: 3325832
    [No Abstract]   [Full Text] [Related]  

  • 18. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    Kaminski MS; Kitamura K; Maloney DG; Levy R
    J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.
    Berinstein N; Levy R
    J Immunol; 1987 Aug; 139(3):971-6. PubMed ID: 3496394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.